Top Medical Products Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Medical Products Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Medical Products industry players.

Medical Products Market Competitive Landscape

The global market is highly fragmented, with the availability of significant market players such as Medtronic, Johnson & Johnson Services, Inc., Abbott, and Stryker accounting for a significant share in 2021. To strengthen their global market position, the top market participants focus on tactics such as acquisitions, collaborations, new product development, and launches. For instance, In March 2022, Accelerate Diagnostics, Inc, launched the Arc Module and BC Kit for automated rapid and accurate identification of bacteria for positive blood cultures.

Top Players in Medical Products Market

  • Medtronic plc (Ireland) 
  • Johnson & Johnson (USA) 
  • Abbott Laboratories (USA) 
  • Stryker Corporation (USA) 
  • Becton, Dickinson and Company (BD) (USA) 
  • Boston Scientific Corporation (USA) 
  • 3M Company (USA) 
  • Zimmer Biomet Holdings, Inc. (USA) 
  • Edwards Lifesciences Corporation (USA) 
  • Smith & Nephew plc (UK) 
  • Koninklijke Philips N.V. (Netherlands) 
  • Siemens Healthineers AG (Germany) 
  • Cardinal Health, Inc. (USA) 
  • Thermo Fisher Scientific Inc. (USA) 
  • Hologic, Inc. (USA) 
  • ResMed Inc. (USA) 
  • Baxter International Inc. (USA) 
  • Fresenius Medical Care AG & Co. KGaA (Germany) 
  • Straumann Holding AG (Switzerland) 
  • Nipro Corporation (Japan)

Medical Products Market Recent Development

  • In August 2022, Cooper Vision launched Beyond the Limbus Master training for scleral lens fitters. The series provides advanced training for intermediate and advanced scleral lens fitters, as well as basic training for support staff and ECPs.
  • In January 2022, Medtronic's Intellis rechargeable neurostimulator and Vanta recharge-free neurostimulator have been approved by the US Food and Drug Administration for the treatment of chronic pain associated with diabetic peripheral neuropathy.
  • In August 2022, Alcon announced the acquisition of Aerie Pharmaceuticals, expanding its ophthalmic pharmaceutical portfolio.
  • In May 2022, Rodenstock acquired Indo Optical, a leading Spanish lens manufacturer, accelerating its growth in key markets.
REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Medical Products Market size was valued at USD 542.55 Billion in 2023 and is poised to grow from USD 579.23 Billion in 2024 to USD 977.51 Billion by 2032, growing at a CAGR of 6.76% during the forecast period (2025-2032).

The global market is highly fragmented, with the availability of significant market players such as Medtronic, Johnson & Johnson Services, Inc., Abbott, and Stryker accounting for a significant share in 2021. To strengthen their global market position, the top market participants focus on tactics such as acquisitions, collaborations, new product development, and launches. For instance, In March 2022, Accelerate Diagnostics, Inc, launched the Arc Module and BC Kit for automated rapid and accurate identification of bacteria for positive blood cultures. 'Medtronic plc (Ireland) ', 'Johnson & Johnson (USA) ', 'Abbott Laboratories (USA) ', 'Stryker Corporation (USA) ', 'Becton, Dickinson and Company (BD) (USA) ', 'Boston Scientific Corporation (USA) ', '3M Company (USA) ', 'Zimmer Biomet Holdings, Inc. (USA) ', 'Edwards Lifesciences Corporation (USA) ', 'Smith & Nephew plc (UK) ', 'Koninklijke Philips N.V. (Netherlands) ', 'Siemens Healthineers AG (Germany) ', 'Cardinal Health, Inc. (USA) ', 'Thermo Fisher Scientific Inc. (USA) ', 'Hologic, Inc. (USA) ', 'ResMed Inc. (USA) ', 'Baxter International Inc. (USA) ', 'Fresenius Medical Care AG & Co. KGaA (Germany) ', 'Straumann Holding AG (Switzerland) ', 'Nipro Corporation (Japan)'

Chronic diseases, such as diabetes, cancer, and other infectious diseases, are becoming more common as a result of sedentary lifestyles and other factors. Furthermore, various countries' healthcare agencies are concentrating on raising treatment and diagnosis rates through an increasing number of awareness programmes. The affected person requiring diagnostic procedures and tests is growing in tandem with the growing incidence and consciousness of such conditions among the general population. According to the International Diabetes Federation (IDF), an estimated 537 million people had diabetes in 2021, with that number expected to rise to 643 million by 2030 and 783 million by 2045. Similarly, the American Cancer Society estimates that 1.9 million new cancer cases will be diagnosed in 2021.

Following the coronavirus pandemic, medical technologies such as wearables are becoming more common. To contain the spread of COVID-19, the need to diagnose, treat, and monitor patients without human contact has increased, resulting in more implementations of medical technologies that will allow healthcare professionals to remotely treat their patients. Artificial intelligence (AI) applications in human care, wearable medical equipment, remote monitoring of patients’ devices, electronic health information (Electronic healthcare), and other such technologies are few a instances. These medical-technical solutions enable contactless monitoring of patients, either at home or in hospitals, which is critical for COVID-19 containment. For example, by maintaining a patient's Electronic Health Records (EHRs), doctors and patients alike can avoid handling traditional paperwork that is passed through several individuals involved in the care and can easily access the information on their own devices.

In 2021, the North American market was worth USD 198.84 billion. The presence of adequate and advantageous favorable reimbursement, well-developed health-care facilities, rapid adoption of cutting-edge medical technologies, and key players in the geographical area are major factors driving its dominance. This is exacerbated by the growing number of patients having undergone treatment and diagnosis in the region as the incidence and prevalence of chronic conditions rises. The European market is expected to grow at a rapid pace, owing to rising healthcare expenditures, well-established infrastructure, and increased adoption of sophisticated diagnostic and treatment devices.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Medical Supplies Market
Buy Now GET FREE SAMPLE
Medical Devices Market
Buy Now GET FREE SAMPLE
Medical Packaging Market
Buy Now GET FREE SAMPLE
Baby Care Products Market
Buy Now GET FREE SAMPLE
Medical Clothing Market
Buy Now GET FREE SAMPLE
Pharmaceuticals Market
Buy Now GET FREE SAMPLE
Home Medical Equipment Market
Buy Now GET FREE SAMPLE
Medical Electronics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Medical Products Market
Medical Products Market

Report ID: SQMIG35B2143

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE